Indian Council of Medical Research (ICMR) in partnership with Serum Institute of India (SII) had conducted phase II/III bridging studies of COVISHIELD from August 2020. Phase III efficacy clinical trials for COVAXIN were also conducted by Bharat Biotech International Limited (BBIL) from November 2020. The Union Ministry of Health and Family Welfare had received several requests from the trial participants for digital vaccination certificates through Co-WIN.
It was decided that vaccination certificates may be issued to such participants who were administered the vaccines during these trials/studies, after the trials/studies were unblinded. ICMR was designated by the Union Health Ministry as the nodal agency for collection of vaccination data for such participants. ICMR had provided the data for 11,349 such persons to the MoHFW. Digital vaccination certificates have now been issued through Co-WIN, to such persons who participated in these studies/trials of COVISHIELD and COVAXIN.
The participants would be able to download their individual certificates through Co-WIN Portal, Aarogya Setu, Digilocker or UMANG Application.
India’s Cumulative COVID-19 Vaccination Coverage crosses 58.82 Cr
India’s COVID-19 vaccination coverage has crossed 58.82 Crore (58,82,21,623) as per the 7 pm provisional report on Monday. More than 56 lakh (56,10,116) Vaccine Doses have been administered today, as per the 7 pm provisional report.
As on Day-220 of the vaccination drive (23rd August, 2021), 39,62,091 were vaccinated for 1st dose and 16,48,025 beneficiaries received 2nd dose of vaccine as per the provisional report till 7 P.M. Final reports would be completed for the day by late yesterday night.
The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.
